Related content

A phase I safety and pharmacokinetic study of OGT 719 in patients with liver cancer

By Mok Tony   Leung Thomas   Brown Gill   Moyses Chris   Chan Anthony   Yeo Winnie   Wong Herman   Chak Karen   Johnson Philip  

Acta Oncologica, Vol. 43, Iss. 3, 2004-04 ,pp. : 245-251

Informa Healthcare

Access to resources Recommend Favorite

Safety and efficacy of decitabine in combination with temozolomide in metastatic melanoma: a phase I/II study and pharmacokinetic analysis

By Tawbi H. A.   Beumer J. H.   Tarhini A. A.   Moschos S.   Buch S. C.   Egorin M. J.   Lin Y.   Christner S.   Kirkwood J. M.  

Annals of Oncology, Vol. 24, Iss. 4, 2013-04 ,pp. : 1112-1119

Oxford University Press

Access to resources Recommend Favorite

A phase I study of the safety and pharmacokinetics of edotecarin (J-107088), a novel topoisomerase I inhibitor, in patients with advanced solid tumors

By Hurwitz Herbert   Cohen Roger   McGovren J.   Hirawat Samit   Petros William   Natsumeda Yutaka   Yoshinari Tomoko  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 1, 2007-01 ,pp. : 139-147

Springer Publishing Company

Access to resources Recommend Favorite

A phase I open-label study evaluating the cardiovascular safety of sorafenib in patients with advanced cancer

By Tolcher Anthony   Appleman Leonard   Shapiro Geoffrey   Mita Alain   Cihon Frank   Mazzu Arthur   Sundaresan Pavur  

Cancer Chemotherapy and Pharmacology, Vol. 67, Iss. 4, 2011-04 ,pp. : 751-764

Springer Publishing Company

Access to resources Recommend Favorite

Phase II study evaluating the efficacy and safety of sagopilone (ZK-EPO) in patients with metastatic breast cancer that has progressed following chemotherapy

By Morrow Phuong   Divers Stephen   Provencher Louise   Luoh Shiuh-Wen   Petrella Teresa   Giurescu Marius   Schmelter Thomas   Wang Yao   Hortobagyi Gabriel   Vahdat Linda  

Breast Cancer Research and Treatment, Vol. 123, Iss. 3, 2010-10 ,pp. : 837-842

Springer Publishing Company

Access to resources Recommend Favorite